insights_auto
Why is ALCOX down 5.75%?
Dive Deeperchevron_right
ALCOX:EPA
NicOx SA
€0.30
arrow_downward
-5.75%(-0.018) 1D
Oct 8, 5:35:15 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCOX...
Open
€0.31
High
€0.31
Low
€0.30
Mkt. cap
29.06M
Avg. vol.
170.04K
Volume
250.70K
52-wk high
€0.57
52-wk low
€0.28
EPS
-€0.03
Shares outstanding
97.55M
No. of employees
10
Open
€0.31
High
€0.31
Low
€0.30
Mkt. cap
29.06M
Avg. vol.
170.04K
Volume
250.70K
52-wk high
€0.57
52-wk low
€0.28
EPS
-€0.03
Shares outstanding
97.55M
No. of employees
10
News stories
From web sources and news partners
巴士的報
·
1 hour ago
U.S. stocks close mixed on Thursday
BeInCrypto
·
35 minutes ago
Current S&P 500 Bull Market Turns 4 Monday and History Suggests More to Come
Insurance Journal
·
50 minutes ago
AI Bubble Risks Worst S&P 500 Crash Since 2008, Strategist Says
24/7 Wall St.
·
9 hours ago
XLG Cuts the S&P 500 Down to 50 Stocks. The Result Is an Index Fund Built Entirely Around Mega-Caps
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees10
Founded1996
HeadquartersValbonne, Provence-Alpes-Côte d'Azur, France
SectorBiotechnology
Websitenicox.com